Inhaled insulin (Afrezza; MannKind Corporation) continues to build a case for broader adoption in pediatric diabetes care.

After FDA approval for children 6 and older, ADA data show inhaled insulin's safety and satisfaction benefits, but clinician ...

The approval of a new oral postexposure prophylaxis for COVID-19 marks a significant advancement in the disease's prevention ...

Men and urban minority patients with early-onset CRC face elevated CVD death risk, highlighting gaps in survivorship care and ...

The Medicare GLP-1 Bridge's July 1 launch is now the only concrete milestone on the calendar. Whether it becomes the ...

Mixed κ agonism and μ antagonism/partial agonism raises mechanistic and abuse-liability questions, with nausea, vomiting, ...

The moisturizer, sunscreen, or shampoo used in daily routines may contain dozens of plastic-associated chemicals linked to ...

Ajai Chari, MD, unpacks resistance mechanisms, treatment sequencing, and why myeloma’s future may be brighter than anyone ...

SEER-Medicare data (n=54,344; mean age 77.7 years) showed significant unadjusted Black-White gaps in localized diagnosis, ...

Alexa Simon Meara, MD, MS, discusses breaking down silos between academic and community oncology to improve immunotherapy ...

Objective: To compare the real-world effects of weekly injectable semaglutide (Ozempic) vs dulaglutide (Trulicity) on weight ...

Among those who received a prior authorization denial, 41% said it delayed their medical care, and 28% said their health ...